Global pharma giants Eli Lilly and Novo Nordisk are scrambling to cement their lead in India's booming obesity drug market ...

The Supreme Court has invoked its extraordinary powers under Article 142 of the Constitution to issue a series of steps to ...

Hyderabad: Global pharma heavyweights Eli Lilly and Novo Nordisk are racing to lock in market leadership in India’s blooming ...

The British doctor called on his followers to complain to Australian health regulators and the anaesthetist’s employer, ...

India’s pharmaceutical market is currently valued at around $60 billion and is expected to reach about $130 billion by 2030, according to the Department of Pharmaceuticals. Longer-term projections by ...

Kerala got its first BJP mayor, VV Rajesh, after the National Democratic Alliance won Thiruvananthapuram civic body elections ...

Recent advances in DNA sequencing, combined with new stem cell research approaches, have allowed an international group of scientists to identify a previously unrecognized form of diabetes that ...

Eli Lilly and Novo Nordisk are in a race to dominate India's booming obesity drug market. They are using aggressive marketing, doctor outreach and partnerships. Lilly's Mounjaro launched early and is ...

With generic rivals waiting in the wings, Eli Lilly and Novo Nordisk are intensifying efforts to lock in market share in India’s rapidly expanding obesity drug market, turning pricing, promotion, and ...

This is a fit case for this Court to exercise its powers under Article 142 of the Constitution of India,” court said in its ...